Antidote Technologies
Latest round
- Series B
Last raised
- Feb 2015
Total raised
- $17M
Investors
- 3
About Antidote Technologies
a. Antidote operates as a health-tech company that uses precision recruitment to match the right patients with the right trials through the integration of data-driven technologies, domain experience, digital expertise, diverse partner network, and personalized patient and site services. In June 2021, Antidote Technologies, Inc. As of June 2021, Laurent Schockmel is the CEO of the company. Antidote's primary product is a platform that facilitates the vital connections between patients and clinical trials. The company uses precision recruitment to match the right patients with the right trials to strike the right balance between technology and human touch to deliver patient engagement. This solution serves as a crucial link, enabling patients to access and participate in clinical research that can have an impact on their lives. By addressing the challenge of patient recruitment, Antidote is streamlining the process and accelerating medical advancements.
Who invested in Antidote Technologies
3 investors across 2 rounds
See all investors in Antidote Technologies
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Antidote Technologies
Who invested in Antidote Technologies?
Antidote Technologies has 3 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Antidote Technologies raised?
Antidote Technologies has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Antidote Technologies last raise money?
Antidote Technologies's most recent round on record is a Series B, in Feb 2015.
What does Antidote Technologies do?
Antidote Technologies is a healthcare company.
Where is Antidote Technologies headquartered?
Antidote Technologies is headquartered in London, UK.
Which VCs invest in companies like Antidote Technologies?
Among active investors with capital left to deploy, Index Ventures, Forbion, Balderton Capital and Sofinnova Partners back healthcare companies at Antidote Technologies's stage. Their profiles are linked below.
VCs backing healthcare startups at Series B
Raising like Antidote Technologies? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.